Observational Study
Copyright ©The Author(s) 2024.
World J Cardiol. May 26, 2024; 16(5): 282-292
Published online May 26, 2024. doi: 10.4330/wjc.v16.i5.282
Table 1 Distribution of demographic and clinical characteristics of post-acute myocardial infarction patients, n (%)

Total
Statin therapy
P value
Not on recommended dose
On recommended dose
Total19522 (11.3)173 (88.7)-
Gender
    Male139 (71.3)15 (68.2)124 (71.7)0.733
    Female56 (28.7)7 (31.8)49 (28.3)
Age (mean ± SD, yr)57.1 ± 10.257.8 ± 11.657 ± 100.728
    ≤ 4011 (5.6)2 (9.1)9 (5.2)0.558
    41-65150 (76.9)15 (68.2)135 (78)
    > 6534 (17.4)5 (22.7)29 (16.8)
Weight (mean ± SD, kg)73.4 ± 14.776.6 ± 15.272.9 ± 14.60.268
Height (mean ± SD, cm)155.5 ± 7.7159.9 ± 7.5154.9 ± 7.50.004
Body mass index (mean ± SD, kg/m2)30.4 ± 5.830.2 ± 6.630.4 ± 5.80.857
    Underweight (< 18.5)1 (0.5)0 (0)1 (0.6)0.185
    Healthy weight (18.5-22.9)16 (8.2)4 (18.2)12 (6.9)
    Above ideal range (≥ 23)178 (91.3)18 (81.8)160 (92.5)
Waist circumference (mean ± SD, cm)97.2 ± 8.8101.5 ± 11.796.7 ± 8.20.016
DM82 (42.1)11 (50)71 (41)0.423
    Duration of DM (mean ± SD)9.1 ± 5.39.5 ± 6.29.1 ± 5.20.832
    Well controlled13 (15.9)3 (27.3)10 (14.1)0.265
HTN100 (51.3)12 (54.5)88 (50.9)0.745
    Duration of HTN (mean ± SD)8.1 ± 4.46.9 ± 3.48.2 ± 4.50.342
    Well controlled54 (54)11 (91.7)43 (48.9)0.005
Tobacco83 (42.6)6 (27.3)77 (44.5)0.124
    Duration of tobacco use (mean ± SD)19.1 ± 9.115.4 ± 8.219.4 ± 9.20.296
    Chewing6 (7.2)2 (33.3)4 (5.2)0.073
    Chewing, smoking6 (7.2)0 (0)6 (7.8)
    Smoking71 (85.5)4 (66.7)67 (87)
Family history of coronary artery diseases101 (51.8)17 (77.3)84 (48.6)0.011
AMI
    STEMI117 (60)15 (68.2)102 (59)0.406
    NSTEMI78 (40)7 (31.8)71 (41)
Duration science first event of AMI (month)36 (10-48)36 (10-72)30 (10-48)0.299
Number of hospital admissions (in last 12 months)
    0167 (85.6)15 (68.2)152 (87.9)0.001
    123 (11.8)4 (18.2)19 (11)
    25 (2.6)3 (13.6)2 (1.2)
Lipid profile advised after AMI27 (13.8)6 (27.3)21 (12.1)0.053
Are you taken statins after 1st event of AMI?185 (94.9)12 (54.5)173 (100)< 0.001
    Duration [median (IQR), month]24 (9-48)26 (6.5-66)24 (10-48)0.818
What is the dose of statin you are taking?
Rosuvastatin179 (91.8)7 (31.8)172 (99.4)-
    Not taking16 (8.2)15 (68.2)1 (0.6)< 0.001
    10 mg7 (3.6)7 (31.8)0 (0)
    20 mg172 (88.2)0 (0)172 (99.4)
Atervastatin5 (2.6)4 (18.2)1 (0.6)-
    Not taking190 (97.4)18 (81.8)172 (99.4)< 0.001
    20 mg4 (2.1)4 (18.2)0 (0)
    40 mg1 (0.5)0 (0)1 (0.6)
Simvastatin1 (0.5)1 (4.5)0 (0)-
    Not taking194 (99.5)21 (95.5)173 (100)0.005
    10 mg1 (0.5)1 (4.5)0 (0)
Did you ever lipid profile get done before AMI event?4 (2.1)1 (4.5)3 (1.7)0.381
Total cholesterol (last lipid profile)
    Available191 (97.9)22 (100)169 (97.7)-
    Level (mean ± SD)143.1 ± 38.7143 ± 35.6143.1 ± 39.20.986
    Level [median (IQR)]140 (115-165)136 (115-165)144 (115-163)0.818
    Target total cholesterol (< 160)137 (71.7)16 (72.7)121 (71.6)0.912
LDL-cholesterol (last lipid profile)
    Available191 (97.9)21 (95.5)170 (98.3)-
    Level (mean ± SD)91.7 ± 34.894.7 ± 42.591.3 ± 33.80.676
    Level [median (IQR)]88 (66-110)83 (65-94)88.5 (67-110)0.989
    Target LDL cholesterol (< 55)22 (11.5)2 (9.5)20 (11.8)0.762
HDL-cholesterol (last lipid profile)
    Available192 (98.5)22 (100)170 (98.3)-
    Level (mean ± SD)40.9 ± 8.741.2 ± 1040.8 ± 8.60.846
    Level [median (IQR)]42 (36-45)42.5 (37-49)41.5 (36-45)0.466
Triglycerides (last lipid profile)
    Available165 (84.6)17 (77.3)148 (85.5)-
    Level (mean ± SD)167.6 ± 76.4185.4 ± 125165.5 ± 69.10.311
    Level [median (IQR)]150 (123-190)152 (125-167)]150 (123-190)0.782
Were you taken statins before 1st event of AMI?3 (1.5)0 (0)3 (1.7)0.534
    Duration [median (IQR), month]36 (12-48)-36 (12-48)-
History of subsequent ACS event16 (8.2)3 (13.6)13 (7.5)0.324
Compliant to the statin therapy179 (91.8)12 (54.5)167 (96.5)< 0.001
If no what are the reasons?
    Affordability15 (7.7)9 (40.9)6 (3.5)< 0.001
    Dizziness1 (0.5)1 (4.5)0 (0)
Table 2 Univariate and multivariable binary logistic regression analysis for the clinical associates of the target total cholesterol
Target total cholesterol (< 160)
Univariate
Multivariable
OR (95%CI)
P value
OR (95%CI)
P value
Gender
    Male1-1-
    Female1.07 (0.53-2.16)0.8451.43 (0.61-3.38)0.411
Age (yr)
    ≤ 401-1-
    41-650.23 (0.03-1.88)0.1720.18 (0.02-1.53)0.116
    > 650.27 (0.03-2.39)0.2380.18 (0.02-1.74)0.137
Body mass index (kg/m2)
    < 231-1-
    ≥ 230.76 (0.24-2.45)0.6500.75 (0.2-2.73)0.657
Waist circumference (cm)0.99 (0.96-1.03)0.7431 (0.95-1.04)0.859
DM
    Non-DM1-1-
    DM0.96 (0.51-1.82)0.9010.94 (0.47-1.87)0.864
HTN
    Non-HTN1-1-
    HTN0.97 (0.52-1.82)0.9251.06 (0.55-2.06)0.854
Tobacco user
    No1-1-
    Yes1.22 (0.64-2.33)0.5371.43 (0.66-3.14)0.366
Family history of coronary artery diseases
    No1-1-
    Yes1.03 (0.55-1.93)0.9300.94 (0.48-1.81)0.843
Acute myocardial infarction
    STEMI1-1-
    NSTEMI0.98 (0.51-1.85)0.9401.05 (0.54-2.04)0.893
Lipid profile advised after acute myocardial infarction
    No1-1-
    Yes0.71 (0.29-1.7)0.4410.58 (0.23-1.47)0.247
Statin therapy after acute myocardial infarction
    No1-1-
    Yes0.62 (0.13-3.02)0.5540.52 (0.1-2.78)0.446
Table 3 Univariate and multivariable binary logistic regression analysis for the clinical associates of the target low-density lipoprotein cholesterol
Target LDL cholesterol (< 55)
Univariate
Multivariable
OR (95%CI)
P value
OR (95%CI)
P value
Gender
    Male1-1-
    Female1.18 (0.45-3.06)0.7391.09 (0.32-3.72)0.884
Age (yr)
    ≤ 401-1-
    41-650.2 (0.05-0.76)0.0180.17 (0.03-0.85)0.031
    > 650.18 (0.03-0.97)0.0460.14 (0.02-1.07)0.058
Body mass index (kg/m2)
    < 231-1-
    ≥ 230.57 (0.15-2.17)0.4120.34 (0.06-1.84)0.211
Waist circumference (cm)1.02 (0.97-1.08)0.3541.04 (0.98-1.11)0.210
DM
    Non-DM1-1-
    DM0.61 (0.24-1.58)0.3120.4 (0.14-1.17)0.094
HTN
    Non-HTN1-1-
    HTN0.92 (0.38-2.24)0.8550.96 (0.35-2.68)0.942
Tobacco user
    No1-1-
    Yes0.6 (0.23-1.54)0.2890.59 (0.18-1.93)0.386
Family history of coronary artery diseases
    No1-1-
    Yes1.39 (0.57-3.44)0.4701.42 (0.53-3.84)0.485
Acute myocardial infarction
    STEMI1-1-
    NSTEMI0.4 (0.14-1.12)0.0820.41 (0.13-1.31)0.133
Lipid profile advised after acute myocardial infarction
    No1-1-
    Yes0.27 (0.04-2.13)0.2160.15 (0.02-1.39)0.095
Statin therapy after acute myocardial infarction
    No1-1-
    Yes1.04 (0.12-8.76)0.9691.45 (0.11-18.39)0.775
Table 4 Univariate and multivariable binary logistic regression analysis for the clinical associates of the recommended dose of statin
Recommended dose of statin
Univariate
Multivariable
OR (95%CI)
P value
OR (95%CI)
P value
Gender
    Male1-1-
    Female0.85 (0.33-2.2)0.7331.91 (0.55-6.67)0.325
Age (yr)
    ≤ 401-1-
    41-652 (0.39-10.13)0.4021.58 (0.25-9.99)0.395
    > 651.29 (0.21-7.82)0.7830.48 (0.06-4.09)0.213
Body mass index (kg/m2)
    < 231-1-
    ≥ 232.74 (0.81-9.28)0.10714 (2.42-80.95)0.806
Waist circumference (cm)0.94 (0.89-0.99)0.0180.89 (0.83-0.95)0.890
DM
    Non-DM1-1-
    DM0.7 (0.29-1.69)0.4240.64 (0.23-1.79)0.286
HTN
    Non-HTN1-1-
    HTN0.86 (0.35-2.1)0.7451.38 (0.47-4.03)0.354
Tobacco user
    No1-1-
    Yes2.14 (0.8-5.73)0.1302.08 (0.58-7.51)0.799
Family history of coronary artery diseases
    No1-1-
    Yes0.28 (0.1-0.79)0.0160.2 (0.06-0.64)0.098
Acute myocardial infarction
    STEMI1-1-
    NSTEMI1.49 (0.58-3.84)0.4081.6 (0.51-5.06)0.579
Lipid profile advised after acute myocardial infarction
    No1-1-
    Yes0.37 (0.13-1.05)0.0610.21 (0.06-0.74)0.130